Biogen's Q3 Profit Beats Expectations On Lower Multiple Sclerosis Revenues But New Products Offset Losses, Raises Profit Outlook - Biogen ( NASDAQ:BIIB )

2 weeks ago

On Wednesday, Biogen Inc BIIB reported third-quarter adjusted EPS of $4.08, down 6%, beating the consensus of $3.79. The company reported sales of $2.47 billion, down 3% year over on constant currency and reported basis, beating the consensus of $2.43 billion.

Ticker	Sentiment	Impact
BIIB	Neutral	71 %